Marlana M. Orloff, Egle Ramelyte, Marcus O. Butler, Piotr Rutkowski, Lorenza Di Guardo, Matteo S. Carlino, Bartosz Chmielowski, Lucy Boyce Kennedy, Kamaneh Montazeri, Joseph J. Sacco, Ernesto Rossi, Victoria Atkinson, Rizwan Haq, Meredith McKean, George W. Cole, Hetal Patel, Long Kwei, Jasgit C. Sachdev, Darrin M. Beaupre, Sophie Piperno-Neumann. "Darovasertib plus crizotinib vs investigator’s choice as first-line treatment for patients with HLA-A2 negative metastatic uveal melanoma: Primary results from the OptimUM-02 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba9503